Mohan Meera, Samant Rohan S, Yoon Donghoon, Buros Amy F, Branca Antonio, Montgomery Corey O, Nicholas Richard, Suva Larry J, Morello Roy, Thanendrarajan Sharmilan, Schinke Carolina, Yaccoby Shmuel, van Rhee Frits, Davies Faith E, Morgan Gareth J, Zangari Maurizio
Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
J Bone Miner Res. 2017 Jun;32(6):1261-1266. doi: 10.1002/jbmr.3111. Epub 2017 Mar 27.
Osteolytic bone lesions are a hallmark of multiple myeloma (MM) bone disease. Bone destruction is associated with severely imbalanced bone remodeling, secondary to increased osteoclastogenesis and significant osteoblast suppression. Lytic lesions of the pelvis are relatively common in MM patients and are known to contribute to the increased morbidity because of the high risk of fracture, which frequently demands extensive surgical intervention. After observing unexpected radiological improvement in serial large pelvic CT assessment in a patient treated in a total therapy protocol, the radiographic changes of pelvic osteolytic lesions by PET/CT scanning in patients who received Total Therapy 4 (TT4) treatment for myeloma were retrospectively analyzed. Sixty-two (62) patients with lytic pelvic lesions >1 cm in diameter were identified at baseline PET/CT scanning. Follow-up CT studies showed that 27 of 62 patients (43%) with large baseline pelvic lesions achieved significant reaccumulation of radiodense mineralization at the lytic cortical site. The average size of lytic lesions in which remineralization occurred was 4 cm (range, 1.3 to 10 cm). This study clearly demonstrates that mineral deposition in large pelvic lesions occurs in a significant proportion of MM patients treated with TT4, potentially affecting patient outcomes, quality of life, and future treatment strategies. © 2017 American Society for Bone and Mineral Research.
溶骨性骨病变是多发性骨髓瘤(MM)骨病的一个标志。骨破坏与严重失衡的骨重塑相关,这继发于破骨细胞生成增加和成骨细胞显著受抑制。骨盆的溶骨性病变在MM患者中相对常见,并且已知由于骨折风险高而导致发病率增加,这常常需要广泛的手术干预。在观察到一名接受全疗程治疗方案的患者在系列大骨盆CT评估中出现意外的影像学改善后,对接受骨髓瘤全疗程治疗4(TT4)的患者通过PET/CT扫描观察到的骨盆溶骨性病变的影像学变化进行了回顾性分析。在基线PET/CT扫描时,确定了62例直径>1 cm的骨盆溶骨性病变患者。随访CT研究显示,62例基线骨盆大病变患者中有27例(43%)在溶骨性皮质部位实现了放射性致密矿化的显著再蓄积。发生再矿化的溶骨性病变的平均大小为4 cm(范围为1.3至10 cm)。这项研究清楚地表明,在接受TT4治疗的MM患者中,很大一部分患者的大骨盆病变中发生了矿物质沉积,这可能会影响患者的预后、生活质量和未来的治疗策略。©2017美国骨与矿物质研究学会。